Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-03 5:00 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
9,822 | $4.15 | $40,761 | 797,680 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 5:00 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $33.65 | $1,682,622 | 778,828 (Indirect Direct) |
View |
| 2022-08-10 Sale |
2022-08-11 5:00 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $29.9 | $1,495,000 | 807,258 (Indirect Direct) |
View |
| 2022-07-19 Sale |
2022-07-21 5:00 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $29.9 | $1,495,000 | 857,258 (Indirect Direct) |
View |
| 2022-01-04 Sale |
2022-01-06 4:36 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
1,870 | $39.9 | $74,613 | 835,955 (Indirect Direct) |
View |
| 2021-12-27 Sale |
2021-12-29 4:38 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
48,693 | $40.16 | $1,955,534 | 1,113,813 (Indirect Direct) |
View |
| 2021-12-22 Sale |
2021-12-27 6:08 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
114,000 | $39.3 | $4,480,604 | 1,261,506 (Indirect Direct) |
View |
| 2021-06-21 Purchase |
2021-06-21 6:20 pm |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
2,500 | $19 | $47,500 | 622,528 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Exercise |
2025-04-03 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
33,000 | $0 | 797,680 (Direct) |
View |
Ownership |
2025-01-30 4:33 pm |
N/A N/A |
Maze Therapeutics Inc. | MAZE | Kathiresan Sekar Director |
0 | $0 | 133,553 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 09:00 am |
N/A 2035-01-07 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
758,000 | $0 | 758,000 (Direct) |
View |
| 2024-12-04 Gift |
2024-12-04 4:30 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $0 | 675,502 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-02 07:30 am |
N/A 2030-09-15 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $0 | 1,248,430 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-02 07:30 am |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
30,000 | $2.87 | 1,248,430 (Direct) |
View |
| 2024-06-03 Option Award |
2024-06-05 8:04 pm |
N/A 2034-06-02 |
Relay Therapeutics Inc. | RLAY | Kathiresan Sekar Director |
102,225 | $0 | 102,225 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:30 pm |
N/A 2034-02-13 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
658,000 | $0 | 658,000 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-01 6:39 pm |
N/A 2033-05-30 |
Relay Therapeutics Inc. | RLAY | Kathiresan Sekar Director |
66,055 | $0 | 66,055 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 5:00 pm |
N/A 2033-02-13 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
550,200 | $0 | 550,200 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 5:00 pm |
N/A 2029-04-14 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $0 | 778,828 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $1.39 | 778,828 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-11 5:00 pm |
N/A 2029-04-14 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $0 | 807,258 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-11 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $1.39 | 807,258 (Direct) |
View |
| 2022-07-25 Option Award |
2022-07-27 6:57 pm |
N/A 2032-07-24 |
Relay Therapeutics Inc. | RLAY | Kathiresan Sekar Director |
71,881 | $0 | 71,881 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 5:00 pm |
N/A 2029-04-14 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $0 | 857,258 (Direct) |
View |
| 2022-07-19 Exercise |
2022-07-21 5:00 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
50,000 | $1.39 | 857,258 (Direct) |
View |
| 2022-07-12 Gift |
2022-07-15 5:00 pm |
N/A 2031-02-11 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
760,000 | $0 | 1,817,129 (Direct) |
View |
| 2022-03-18 Exercise |
2022-03-22 07:41 am |
N/A 2030-09-15 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
69,674 | $0 | 1,244,827 (Direct) |
View |
| 2022-03-18 Exercise |
2022-03-22 07:41 am |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
69,674 | $2.87 | 1,244,827 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 08:58 am |
N/A 2032-02-10 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
332,000 | $0 | 332,000 (Direct) |
View |
| 2022-01-04 Exercise |
2022-01-06 4:36 pm |
N/A 2029-04-14 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
1,870 | $0 | 835,955 (Direct) |
View |
| 2022-01-04 Exercise |
2022-01-06 4:36 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
1,870 | $1.39 | 835,955 (Direct) |
View |
| 2021-12-27 Exercise |
2021-12-29 4:38 pm |
N/A 2029-04-14 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
48,693 | $0 | 1,113,813 (Direct) |
View |
| 2021-12-27 Exercise |
2021-12-29 4:38 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
48,693 | $1.39 | 1,113,813 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-27 6:08 pm |
N/A 2029-04-14 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
114,000 | $0 | 1,261,506 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-27 6:08 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
114,000 | $1.39 | 1,261,506 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 6:20 pm |
N/A 2031-06-16 |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer |
53,998 | $0 | 622,528 (Direct) |
View |
Ownership |
2021-06-16 7:42 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer 10% Owner |
0 | $0 | 2,293,983 (Direct) |
View |